Research graph
References from Prevalence, high-risk HPV type profile, and factors associated with high-risk HPV infection among women living with HIV in Kinshasa, Democratic Republic of the Congo. Local targets link to admitted publications; unresolved targets remain external evidence.
Cervical cancer: Epidemiology, risk factors and screening
10.21147/j.issn.1000-9604.2020.06.05 · 2020 · External reference
HIV and cancer of the cervic
10.1016/j.bpobgyn.2004.10.002 · 2005 · External reference
Cervical cancer
10.1016/s0140-6736(18)32470-x · 2019 · External reference
Unresolved reference
2021 · External reference
Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana
10.1371/journal.pone.0218762 · 2019 · External reference
Geneva: World Health Organization; 2021
External reference
Cervical cancer prevention and control in women living with human immunodeficiency virus
10.3322/caac.21696 · 2021 · External reference
Cervical cancer screening: past, present, and future
10.1016/j.sxmr.2019.09.005 · 2020 · External reference
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa
10.1007/s10552-009-9475-z · 2010 · External reference
Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa
10.1016/j.gofs.2021.07.001 · 2022 · External reference
Prevalence and distribution of human papillomavirus genotypes among women in Kinshasa, The Democratic Republic of the Congo
10.1200/jgo.19.00110 · 2019 · External reference
Human papillomavirus and cervical cancer
10.1016/s0140-6736(13)60022-7 · 2013 · External reference
Épidémiologie et caractérisation des génotypes à haut risque de Papillomavirus humain dans une population d'adolescentes sexuellement actives à Ouagadougou
10.1016/j.jgyn.2014.12.021 · 2015 · External reference
High-risk human papillomavirus genotyping in cervical cancers in Tanzania
10.1186/s13027-024-00596-1 · 2024 · External reference
Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa
10.1016/j.pvr.2018.09.001 · 2018 · External reference
Mucosal and cutaneous human papillomavirus infections and cancer biology
10.3389/fonc.2019.00355 · 2019 · External reference
and cancer: Mechanisms of oncogenesis
10.1016/s1773-035x(08)74276-x · 2008 · External reference
Cervical cancer prevention: human papillomavirus testing as primary screening
10.1002/cncr.34006 · 2022 · External reference
Estimates of the global burden of cervical cancer associated with HIV
10.1016/s2214-109x(20)30459-9 · 2021 · External reference
Lin, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
10.1016/s2352-3018(17)30149-2 · 2018 · External reference
Human papillomavirus, human immunodeficiency virus and immunosuppression
10.1016/j.vaccine.2012.06.045 · 2012 · External reference
Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation
10.1128/jcm.44.5.1788-1791.2006 · 2006 · External reference
Principles and analytical performance of Abbott real time high risk HPV test
10.1016/s1386-6532(09)70003-4 · 2009 · External reference
Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)—implications for pathogenicity and vaccine effectiveness
10.3390/microorganisms10122492 · 2022 · External reference
Prevalence and determinants of high-risk human papillomavirus infection in women from a Sub-Saharan African community
10.1097/olq.0b013e3181fc6ec0 · 2011 · External reference
Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease
10.1080/14787210.2017.1322902 · 2017 · External reference
Fréquence, persistance et récidive des lésions à HPV du col utérin chez les patientes séropositives pour le VIH
10.1016/j.gyobfe.2008.02.007 · 2008 · External reference
Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia
10.1186/s12905-024-03249-y · 2024 · External reference
Risk factors for high-risk and multi-type human papillomavirus infections among women in Ho Chi Minh city, Vietnam: a cross-sectional study
10.1186/s12905-015-0172-7 · 2015 · External reference
Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross-sectional study
10.1186/s12889-024-19240-z · 2024 · External reference
The prevalence of human papillomavirus in women living with HIV in Mukono general hospital, Uganda
10.34172/ehsj.25209 · 2023 · External reference
Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda
10.1186/s12885-024-11928-0 · 2024 · External reference
Screening approaches for cervical cancer in Mozambique in HIV positive and negative women
10.1097/cej.0000000000000802 · 2023 · External reference
Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy
External reference
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women
10.1371/journal.pone.0257324 · 2021 · External reference
HPV Types in cervical precancer by HIV status and birth region: a population-based register study
10.1158/1055-9965.epi-20-0969 · 2020 · External reference
Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms
10.1186/s12905-024-03232-7 · 2024 · External reference
Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana
10.1371/journal.pone.0303535 · 2024 · External reference
High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting
10.1186/s13027-023-00513-y · 2023 · External reference
High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa
10.1097/qad.0000000000003437 · 2023 · External reference
The natural history of human papillomavirus infection
10.1016/j.bpobgyn.2017.08.015 · 2018 · External reference
Cervical cancer prevention: human papillomavirus testing as primary screening
10.1002/cncr.34006 · ExternalCitation · doi-reference
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa
10.1007/s10552-009-9475-z · ExternalCitation · doi-reference
HIV and cancer of the cervic
10.1016/j.bpobgyn.2004.10.002 · ExternalCitation · doi-reference
The natural history of human papillomavirus infection
10.1016/j.bpobgyn.2017.08.015 · ExternalCitation · doi-reference
Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa
10.1016/j.gofs.2021.07.001 · ExternalCitation · doi-reference
Fréquence, persistance et récidive des lésions à HPV du col utérin chez les patientes séropositives pour le VIH
10.1016/j.gyobfe.2008.02.007 · ExternalCitation · doi-reference
Épidémiologie et caractérisation des génotypes à haut risque de Papillomavirus humain dans une population d'adolescentes sexuellement actives à Ouagadougou
10.1016/j.jgyn.2014.12.021 · ExternalCitation · doi-reference
Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa
10.1016/j.pvr.2018.09.001 · ExternalCitation · doi-reference
Cervical cancer screening: past, present, and future
10.1016/j.sxmr.2019.09.005 · ExternalCitation · doi-reference
Human papillomavirus, human immunodeficiency virus and immunosuppression
10.1016/j.vaccine.2012.06.045 · ExternalCitation · doi-reference
Human papillomavirus and cervical cancer
10.1016/s0140-6736(13)60022-7 · ExternalCitation · doi-reference
Cervical cancer
10.1016/s0140-6736(18)32470-x · ExternalCitation · doi-reference
Principles and analytical performance of Abbott real time high risk HPV test
10.1016/s1386-6532(09)70003-4 · ExternalCitation · doi-reference
and cancer: Mechanisms of oncogenesis
10.1016/s1773-035x(08)74276-x · ExternalCitation · doi-reference
Estimates of the global burden of cervical cancer associated with HIV
10.1016/s2214-109x(20)30459-9 · ExternalCitation · doi-reference
Lin, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
10.1016/s2352-3018(17)30149-2 · ExternalCitation · doi-reference
Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease
10.1080/14787210.2017.1322902 · ExternalCitation · doi-reference
Screening approaches for cervical cancer in Mozambique in HIV positive and negative women
10.1097/cej.0000000000000802 · ExternalCitation · doi-reference
Prevalence and determinants of high-risk human papillomavirus infection in women from a Sub-Saharan African community
10.1097/olq.0b013e3181fc6ec0 · ExternalCitation · doi-reference
High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa
10.1097/qad.0000000000003437 · ExternalCitation · doi-reference
Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation
10.1128/jcm.44.5.1788-1791.2006 · ExternalCitation · doi-reference
HPV Types in cervical precancer by HIV status and birth region: a population-based register study
10.1158/1055-9965.epi-20-0969 · ExternalCitation · doi-reference
Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda
10.1186/s12885-024-11928-0 · ExternalCitation · doi-reference
Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross-sectional study
10.1186/s12889-024-19240-z · ExternalCitation · doi-reference
Risk factors for high-risk and multi-type human papillomavirus infections among women in Ho Chi Minh city, Vietnam: a cross-sectional study
10.1186/s12905-015-0172-7 · ExternalCitation · doi-reference
Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms
10.1186/s12905-024-03232-7 · ExternalCitation · doi-reference
Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia
10.1186/s12905-024-03249-y · ExternalCitation · doi-reference
High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting
10.1186/s13027-023-00513-y · ExternalCitation · doi-reference
High-risk human papillomavirus genotyping in cervical cancers in Tanzania
10.1186/s13027-024-00596-1 · ExternalCitation · doi-reference
Prevalence and distribution of human papillomavirus genotypes among women in Kinshasa, The Democratic Republic of the Congo
10.1200/jgo.19.00110 · ExternalCitation · doi-reference
Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana
10.1371/journal.pone.0218762 · ExternalCitation · doi-reference
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women
10.1371/journal.pone.0257324 · ExternalCitation · doi-reference
Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana
10.1371/journal.pone.0303535 · ExternalCitation · doi-reference
Cervical cancer: Epidemiology, risk factors and screening
10.21147/j.issn.1000-9604.2020.06.05 · ExternalCitation · doi-reference
Cervical cancer prevention and control in women living with human immunodeficiency virus
10.3322/caac.21696 · ExternalCitation · doi-reference
Mucosal and cutaneous human papillomavirus infections and cancer biology
10.3389/fonc.2019.00355 · ExternalCitation · doi-reference
Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)—implications for pathogenicity and vaccine effectiveness
10.3390/microorganisms10122492 · ExternalCitation · doi-reference
The prevalence of human papillomavirus in women living with HIV in Mukono general hospital, Uganda
10.34172/ehsj.25209 · ExternalCitation · doi-reference
